LAUREN BERGLIND: Open Payments
NPI 1265092076 · SILVERDALE, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$576 in 25 payments from 11 companies in 2025. Trend: 2023 $193 · 2024 $1,193 · 2025 $576
Food & beverage: $576
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 8 | $151 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $110 |
| Lilly USA, LLC | 2 | $58 |
| Medtronic, Inc. | 2 | $53 |
| Janssen Biotech, Inc. | 2 | $45 |
| Madrigal Pharmaceuticals | 1 | $42 |
| GENZYME CORPORATION | 1 | $35 |
| Regeneron Healthcare Solutions, Inc. | 1 | $27 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $22 |
| PFIZER INC. | 1 | $17 |
Products named: ENTYVIO, LINZESS, DUPIXENT, OMVOH, SKYRIZI, TREMFYA, REZDIFFRA, GI GENIUS.
Industry payments across WA — which companies pay providers there.
